Clinical Trials Browser

Phase 1 × Solid Tumors × selicrelumab × Clear all

NCT02304393 2019-12-13

A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumors